Inventor · disambiguated record
John D. Shaughnessy
Also filed as: SHAUGHNESSY JOHN D · SHAUGHNESSY JR JOHN D
25 granted patents·18 pending applications·327 citations·filing 2001–2021
96Inventor score
Files withUNIV ARKANSAS13SHAUGHNESSY JR JOHN D12SHAUGHNESSY JOHN D6BIOVENTURES LLC5DEPINHO RONALD A2
Top patents by PatentIndex Score
43 records- 0195US7642238B2Molecular determinants of myeloma bone disease and uses thereofSHAUGHNESSY JOHN D·Filed 2005·Granted Jan 5, 2010·55 cites·4 claims
- 0295US7308364B2Diagnosis of multiple myeloma on gene expression profilingUNIV ARKANSAS MED SCIENCES·Filed 2003·Granted Dec 11, 2007·112 cites·2 claims
- 0393US8211634B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancerDEPINHO RONALD A·Filed 2007·Granted Jul 3, 2012·37 cites·16 claims
- 0492US8843320B2Use of gene expression profiling to predict survival in cancer patientSHAUGHNESSY JOHN D·Filed 2005·Granted Sep 23, 2014·14 cites·6 claims
- 0591US7935679B2Gene expression profiling based identification of CKS1B as a potential therapeutic target in multiple myelomaUNIV ARKANSAS·Filed 2005·Granted May 3, 2011·11 cites·4 claims
- 0691US7371736B2Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone lossUNIV ARKANSAS·Filed 2004·Granted May 13, 2008·25 cites·2 claims
- 0790US7741035B2Use of gene expression profiling to predict survival in cancer patientUNIV ARKANSAS·Filed 2005·Granted Jun 22, 2010·9 cites·4 claims
- 0889US7983850B2Diagnosis, prognosis, identification, and classification of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2008·Granted Jul 19, 2011·6 cites·9 claims
- 0988US7094886B2Evi27 gene sequences and protein encoded therebyUNIV ARKANSAS·Filed 2001·Granted Aug 22, 2006·14 cites·4 claims
- 1086US9309564B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancerDEPINHO RONALD A·Filed 2012·Granted Apr 12, 2016·5 cites·10 claims
- 1184US7668659B2Diagnosis and classification of multiple myelomaUNIV ARKANSAS·Filed 2002·Granted Feb 23, 2010·12 cites·4 claims
- 1282US8954283B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JR JOHN D·Filed 2009·Granted Feb 10, 2015·4 cites·4 claims
- 1382US7811750B2Molecular determinants of myeloma bone disease and use thereofUNIV ARKANSAS·Filed 2006·Granted Oct 12, 2010·2 cites·2 claims
- 1481US9650677B2Use of gene expression profiling to predict survival in cancer patientUNIV ARKANSAS·Filed 2013·Granted May 16, 2017·1 cites·7 claims
- 1579US7696150B2Modulation of the activity of an interleukin 17 receptor-related protein, EVI27, and uses thereofUNIV ARKANSAS·Filed 2005·Granted Apr 13, 2010·2 cites·5 claims
- 1678US7894992B2Diagnosis and classification of multiple myelomaUNIV ARKANSAS·Filed 2003·Granted Feb 22, 2011·5 cites·4 claims
- 1777US7723301B2Pharmaceutical compositions comprising an anti-teratogenic compound and applications of the sameUNIV ARKANSAS·Filed 2007·Granted May 25, 2010·2 cites·8 claims
- 1876US7459437B2Molecular determinants of myeloma bone disease and uses thereofUNIV ARKANSAS MED SCIENCES·Filed 2003·Granted Dec 2, 2008·8 cites·4 claims
- 1973US2020270691A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingBIOVENTURES LLC·Filed 2020·Application pending·0 cites
- 2070US8124087B2Methods of controlling bone loss by inhibiting DKK1SHAUGHNESSY JR JOHN D·Filed 2008·Granted Feb 28, 2012·1 cites·7 claims
- 2168US10597729B2Use of gene expression profiling to predict survival in cancer patientBIOVENTURES LLC·Filed 2017·Granted Mar 24, 2020·0 cites·8 claims
- 2268US2020291486A1Use of gene expression profiling to predict survival in cancer patientBIOVENTURES LLC·Filed 2020·Application pending·0 cites
- 2367US8992909B2Methods of increasing bone mass in a subject comprising inhibiting DKK1SHAUGHNESSY JR JOHN D·Filed 2012·Granted Mar 31, 2015·1 cites·3 claims
- 2466US8501702B2Overexpression of Wnt ligands and treatment of lytic bone diseasesSHAUGHNESSY JR JOHN D·Filed 2007·Granted Aug 6, 2013·1 cites·24 claims
- 2563US2008234139A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 2662US10577656B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingBIOVENTURES LLC·Filed 2017·Granted Mar 3, 2020·0 cites·17 claims
- 2762US9714451B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2013·Granted Jul 25, 2017·0 cites·4 claims
- 2862US9574238B2Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingUNIV ARKANSAS·Filed 2013·Granted Feb 21, 2017·0 cites·13 claims
- 2959US2011319470A1Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profilingSHAUGHNESSY JOHN D·Filed 2011·Application pending·0 cites
- 3057US2023293649A1Cst6, cells expressing cst6 and methods of useBIOVENTURES LLC·Filed 2021·Application pending·0 cites
- 3155US2008234138A1TP53 gene expression and uses thereofSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 3254US2008280779A1Gene expression profiling based identification of genomic signatures of multiple myeloma and uses thereofSHAUGHNESSY JR JOHN D·Filed 2007·Application pending·0 cites
- 3354US2008274911A1Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereofBURINGTON BART E·Filed 2008·Application pending·0 cites
- 3452US2008187930A1Gene expression profiling based identification of genomic signature of high-risk multiple myeloma and uses thereofSHAUGHNESSY JOHN D·Filed 2007·Application pending·0 cites
- 3551US2010152136A1TP53 Gene expression and uses thereofSHAUGHNESSY JR JOHN D·Filed 2009·Application pending·0 cites
- 3646US2014079813A1Genes Associated With Post Relapse Survival And Uses ThereofEPSTEIN JOSHUA·Filed 2012·Application pending·0 cites
- 3745US2013209446A1Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic TargetsSHAUGHNESSY JR JOHN D·Filed 2011·Application pending·0 cites
- 3844US2011269638A1Genes associated with post relapse survival and uses thereofEPSTEIN JOSHUA·Filed 2011·Application pending·0 cites
- 3943US2013059746A1Gene expression profiling of cytogenetic abnormalitiesSHAUGHNESSY JR JOHN D·Filed 2012·Application pending·0 cites
- 4042US2015140016A1Molecular Determinants of Myeloma Bone Disease and Uses ThereofSHAUGHNESSY JR JOHN D·Filed 2015·Application pending·0 cites
- 4138US2012015906A1Uses of bortezomib in predicting survival in multiple myeloma patientsSHAUGHNESSY JR JOHN D·Filed 2010·Application pending·0 cites
- 4236US2012269802A1Treatment And Prognosis With Thalidomide In Multiple Myeloma Based on Karyotyping And Gene Expression ProfilingSHAUGHNESSY JR JOHN D·Filed 2010·Application pending·0 cites
- 4335US2010316629A1Use of gene expression profiling to predict survival in cancer patientSHAUGHNESSY JR JOHN D·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John D. Shaughnessy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →